(*contributed equally to this work) 发布: 2017年05月05日第7卷第9期 DOI: 10.21769/BioProtoc.2250 浏览次数: 8663
评审: Valentine V TrotterChristian RothAnonymous reviewer(s)
Abstract
The meningococcus (Neisseria meningitidis) remains an important threat to human healthworldwide. This Gram-negative bacterium causes elevated disabilities and mortality in infectedindividuals. Despite several available vaccines, currently there is no universal vaccine against allcirculating meningococcal strains (Vogel et al., 2013). Herein, we describe a new protocol that iscapable of identifying only cell surface exposed proteins that play a role in immunity, providing thisresearch field with a more straightforward approach to identify novel vaccine targets. Even though N. meningitidis is used as a model in the protocol herein described, this protocol can be used for anyGram-negative bacteria provided modifications and optimizations are carried out to adapt it to differentbacterial and disease characteristics (e.g., membrane fragility, growth methods, serum antibody levels,etc.).
Keywords: Gram-negative (革兰氏阴性)Background
Attempts to develop novel vaccines against N. meningitidis often rely on 2D SDS-PAGE (two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and Western blotfollowed by MS (mass spectrometry) (Wheeler et al., 2007). However, such approach employs wholecell lysate, identifying a plethora of proteins that do not have vaccine potential (Mendum et al., 2009).We therefore aimed at developing a method capable of identifying only cell surface exposed proteinsthat might play important role in immunity. Briefly, our protocol consists in growing the pathogen ofinterest, immunoprecipitating surface antigens with sera of immune individuals, and identifyingimmunoprecipitated proteins by liquid chromatography-tandem mass spectrometry. We were able toidentify 23 meningococcal surface antigens using this new protocol, some of which are components ofcommercially available vaccines (Newcombe et al., 2014). We also have adapted this protocol to otherGram-negative bacteria and have obtained promising results: we identified previously describedsurface-exposed proteins, many of which have already been tested as vaccine or diagnostic testcandidates. These results show this is a robust technique that can be applied to a diverse range ofGram-negative bacteria and capable of yielding high-quality results that can be further exploited by amyriad of applications (e.g., vaccines, diagnosis, etc.).
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2017 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
da Cunha, C. E. P., Newcombe, J., Dellagostin, O. A. and McFadden, J. (2017). Immunoprecipitation of Cell Surface Proteins from Gram-negative Bacteria. Bio-protocol 7(9): e2250. DOI: 10.21769/BioProtoc.2250.
分类
微生物学 > 微生物生物化学 > 蛋白质
生物化学 > 蛋白质 > 免疫检测
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link